“Imagine how many lives could be saved if we spent as much energy on rare disease awareness and education as we do on celebrity culture.” Patient advocacy groups (PAGs) are critical in bridging the ...
For decades, steroids have been considered a necessary evil to control ANCA-associated vasculitis. Yet today, more patients die from complications associated with glucocorticoid treatment than from ...
In October 2021, the US Food and Drug Administration issued its first new drug approval for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in a decade. The first-in-class ...